Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma
Respiratory Medicine, 09/14/09
Boulet LP et al. – In mild asthma, keeping a regular minimal dose of ICS after asthma control has been achieved, may lead to a further reduction in airway responsiveness and keep sputum eosinophil count within the normal range.
Related Articles
Effect of Fluticasone With and Without Salmeterol on Pulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Annals of Internal Medicine, 10/20/09
Relevance Score: 92%
Parasternal muscle activity decreases in severe COPD with salmeterol-fluticasone propionate
Chest, 10/20/09
Relevance Score: 84%
Mometasone furoate vs fluticasone propionate with salmeterol: multivariate analysis of resource use and asthma-related charges
Current Medical Research and Opinion, 10/19/09
Relevance Score: 80%
Add-on salmeterol compared to double dose fluticasone in pediatric asthma: A double-blind, randomized trial (VIAPAED)
Pediatric Pulmonology, 10/14/09
Relevance Score: 80%
Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes
COPD: Journal of Chronic Obstructive Pulmonary Disease, 10/06/09
Relevance Score: 80%
Today in Asthma/Atopy...keeping you current
Receive free subspecialty "5-minute updates" via email
Adherence Feedback to Improve Asthma Outcomes Among Inner-City Children
Pediatrics, 12/03/09
Agreement in diagnosing occupational asthma by occupational and respiratory physicians who report to surveillance schemes for work-related ill-health
Occupational and Environmental Medicine, 12/01/09
Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist
Therapeutics and Clinical Risk Management, 12/01/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD: a systematic review and meta-analysis
European Respiratory Journal , 12/03/09
Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis
Journal of Cystic Fibrosis , 12/02/09
Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments
Emergency Medicine Journal, 12/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


